RxDoctor Payments Data

Angela Sun

Clinical Genetics (M.D.) · Cincinnati, OHNPI 1760652267

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,640 of the $2,969 with a category attached, or 88.9%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 90.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $2,694 and has fallen 99.0% since, to $27 in 2025.

$2,969in general payments, 2019–2025

Across 8 payments — averaging $371.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$3K
  • Sanofi$218
  • Ultragenyx Pharmaceutical Inc.$30
  • PTC Therapeutics, Inc.$27
$547,738in research payments, 2019–2025

Across 76 payments — averaging $7207.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$279K
  • Biomarin Pharmaceutical Inc.$165K
  • Ultragenyx Pharmaceutical Inc.$71K
  • Hikma Pharmaceuticals USA$25K
  • Shire North American Group Inc$8K

What the payments were for

  • Consulting fees$2,64089%
  • Travel & lodging$321%
  • Food & beverage$2619%
  • Education$361%

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,969 in reported general payments places this provider in the 75th percentile of 42 clinical genetics (m.d.) providers in Ohio.

See all clinical genetics (m.d.) providers in Ohio

Other clinical genetics (m.d.) in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →